Correlation Between Vigil Neuroscience and Alx Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Alx Oncology Holdings, you can compare the effects of market volatilities on Vigil Neuroscience and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Alx Oncology.

Diversification Opportunities for Vigil Neuroscience and Alx Oncology

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vigil and Alx is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Alx Oncology go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Alx Oncology

Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 0.84 times more return on investment than Alx Oncology. However, Vigil Neuroscience is 1.19 times less risky than Alx Oncology. It trades about -0.05 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.05 per unit of risk. If you would invest  356.00  in Vigil Neuroscience on November 2, 2024 and sell it today you would lose (121.00) from holding Vigil Neuroscience or give up 33.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vigil Neuroscience  vs.  Alx Oncology Holdings

 Performance 
       Timeline  
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Alx Oncology Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Alx Oncology is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Vigil Neuroscience and Alx Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vigil Neuroscience and Alx Oncology

The main advantage of trading using opposite Vigil Neuroscience and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.
The idea behind Vigil Neuroscience and Alx Oncology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.